|Videos|November 19, 2017

Why Do Some People Decide Against Receiving Flu Shots?

William Schaffner, MD, lists some of the common reasons behind why individuals decide against getting their flu shots, and why they should reconsider.

William Schaffner, MD, medical director of the National Foundation for Infectious Diseases, lists some of the common reasons behind why individuals decide against getting their flu shots, and why they should reconsider.

Interview Transcript (modified slightly for readability):

"There are a number of reasons people [use to] avoid [getting the flu vaccine]. They’re busy; they’re running around. Some people are needle-phobic, so they don’t like that. My response is, ‘You’re worried about that? Roll up your sleeve and look the other way. Because you may get a sore arm for a day, but think of the disease that you’re preventing.’’

Then there are some people who are concerned about the effectiveness of the vaccine, and I keep emphasizing that it’s the best possible prevention that we have today. Even if it doesn’t prevent the disease completely, it will make the illness milder. And, that’s the best we can do in medical science today, while my friends in the research lab are working to make a better vaccine.

I like to paraphrase that old French philosopher Voltaire: “Waiting for perfection is the great enemy of the current good.” And we can do a lot of good with our pretty darn good flu vaccine if we give it to as many people as possible.”


Related to this article

GSK's mRNA Influenza Vaccine Moves to Phase 3 Trial
GSK will advance its investigational mRNA seasonal flu vaccine candidate, which targets both hemagglutinin and neuraminidase, into a phase 3 trial in September 2026 after the shot outperformed licensed flu vaccines in a phase 2 study.
REMAP-CAP and the Tamiflu “Pre-Release”: A Set-Up for Disaster
Preliminary REMAP-CAP data suggesting oseltamivir may increase mortality in critically ill ICU influenza patients has sparked polarized reactions, but clinicians should await the full peer-reviewed manuscript before drawing broad conclusions, since the signal comes from a narrow, severely ill population and may reflect a therapeutic window effect rather than a blanket lack of efficacy.
How The Food Safety Surveillance Infrastructure Works in the US
In the first episode of our news series looking at the food safety network, Lynette Johnston, PhD, offers insights into how the federal government surveillance infrastructure operates, and how epidemiologists serve as food detectives in determining bacterial pathogens and potential foodborne outbreaks.
New Diagnositics for Legionella Pneumonia May Streamline Care Continuum
Reported cases of Legionnaires’ disease have been on the rise for the past decade, and identifying Legionella bacteria requires specialized testing in the microbiology lab. Here is a clinical overview of Legionella bacteria, including required testing, treatment, and reporting to public health officials.